Opus Point Partners Management, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Opus Point Partners Management, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$671,000
-30.1%
50,000
-50.0%
1.32%
+58.6%
Q4 2017$960,000
-12.6%
100,0000.0%0.83%
-15.7%
Q3 2017$1,098,000
+21.3%
100,0000.0%0.98%
+18.8%
Q2 2017$905,000
+104.8%
100,000
+102.0%
0.83%
+142.4%
Q1 2016$442,000
-44.4%
49,500
-17.5%
0.34%
-34.9%
Q4 2015$795,000
+412.9%
60,000
+306.8%
0.52%
+510.5%
Q3 2015$155,000
-66.2%
14,750
-1.7%
0.09%
-77.7%
Q1 2015$459,00015,0000.38%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 3,561,052$26,245,0005.86%
Palo Alto Investors LP 5,621,533$41,431,0003.20%
Iron Triangle Partners LP 2,000,000$14,740,0001.75%
Altium Capital Management LP 645,000$4,754,0001.59%
Birchview Capital, LP 269,332$1,985,0001.43%
Rubric Capital Management LP 3,607,443$26,587,0000.96%
Lombard Odier Asset Management (Switzerland) SA 776,053$5,720,0000.45%
RICE HALL JAMES & ASSOCIATES, LLC 1,344,929$9,912,0000.40%
Golden State Equity Partners 41,850$308,0000.16%
Hennion & Walsh Asset Management, Inc. 385,837$2,844,0000.15%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders